Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Net Income: 2018-2024

Historic Net Income for Eton Pharmaceuticals (ETON) over the last 7 years, with Dec 2024 value amounting to -$3.8 million.

  • Eton Pharmaceuticals' Net Income fell 407.34% to -$1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.7 million, marking a year-over-year decrease of 21.91%. This contributed to the annual value of -$3.8 million for FY2024, which is 308.44% down from last year.
  • Eton Pharmaceuticals' Net Income amounted to -$3.8 million in FY2024, which was down 308.44% from -$936,000 recorded in FY2023.
  • Eton Pharmaceuticals' 5-year Net Income high stood at -$936,000 for FY2023, and its period low was -$28.0 million during FY2020.
  • Its 3-year average for Net Income is -$4.6 million, with a median of -$3.8 million in 2024.
  • Per our database at Business Quant, Eton Pharmaceuticals' Net Income spiked by 93.01% in 2021 and then tumbled by 361.43% in 2022.
  • Over the past 5 years, Eton Pharmaceuticals' Net Income (Yearly) stood at -$28.0 million in 2020, then surged by 93.01% to -$2.0 million in 2021, then crashed by 361.43% to -$9.0 million in 2022, then soared by 89.62% to -$936,000 in 2023, then slumped by 308.44% to -$3.8 million in 2024.